A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored.
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment of severe asthma characterised by an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback